Canada Markets close in 3 hrs 50 mins

Cosmos Holdings Inc. (COSM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.83+0.03 (+0.52%)
As of 12:10PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close5.80
Open5.78
Bid5.82 x 1200
Ask5.83 x 1100
Day's Range5.73 - 6.10
52 Week Range0.07 - 23.84
Volume870,083
Avg. Volume58,020,303
Market Cap61.828M
Beta (5Y Monthly)1.56
PE Ratio (TTM)97.17
EPS (TTM)0.06
Earnings DateNov 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Cosmos Health Announces Application for Dual Listing on Upstream

    Cosmos Health Inc. (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that is has begun the application process to dual list its shares on Upstream, the trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").

  • ACCESSWIRE

    Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer

    Cosmos Health Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, is pleased to announce the appointment of Nikos Bardakis, who comes with over two decades of international branded pharmaceutical sector experience, as the Chief Operating Officer (COO).

  • ACCESSWIRE

    Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities

    Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announces that in response to the data obtained through Shareholder Intelligence Services, it has retained services of Wes Christian of Christian Levine Law Group and Alan Pollack of Warshaw Burstein, LLP (the "Firms"), to help the company develop